CRISPR Therapeutics AG (CRSP)
40.72
+0.34
(+0.83%)
USD |
NASDAQ |
Dec 20, 16:00
40.87
+0.15
(+0.37%)
After-Hours: 20:00
CRISPR Therapeutics Total Assets (Quarterly): 2.256B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 22.24B |
| Lonza Group Ltd | 19.89B |
| AC Immune SA | 290.33M |
| Addex Therapeutics Ltd | 14.46M |
| NLS Pharmaceutics Ltd | 1.194M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 316.47M |
| Shareholders Equity (Quarterly) | 1.940B |